PLRX Insider Transactions
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2024-01-23 | Lefebvre Eric | officer: Chief Medical Officer | 199,820 | A-Award | A | 42,900 | 0.00 | 0.00 |
2024-01-23 | Lefebvre Eric | officer: Chief Medical Officer | 85,800 | A-Award | A | 85,800 | 17.44 | 1,496,352.00 |
2024-01-23 | Hull Hans | officer: Chief Business Officer | 216,569 | A-Award | A | 31,500 | 0.00 | 0.00 |
2024-01-23 | Hull Hans | officer: Chief Business Officer | 63,000 | A-Award | A | 63,000 | 17.44 | 1,098,720.00 |
2024-01-23 | Ouimette Mike | officer: General Counsel & Corp. Sec'y | 86,746 | A-Award | A | 31,500 | 0.00 | 0.00 |
2024-01-23 | Ouimette Mike | officer: General Counsel & Corp. Sec'y | 63,000 | A-Award | A | 63,000 | 17.44 | 1,098,720.00 |
2024-01-23 | Cummings Keith Lamont | officer: Chief Financial Officer | 249,855 | A-Award | A | 55,250 | 0.00 | 0.00 |
2024-01-23 | Cummings Keith Lamont | officer: Chief Financial Officer | 110,500 | A-Award | A | 110,500 | 17.44 | 1,927,120.00 |
2024-01-23 | Cheung Lily | officer: Chief Human Resource Officer | 52,000 | A-Award | A | 52,000 | 17.44 | 906,880.00 |
2024-01-23 | Cheung Lily | officer: Chief Human Resource Officer | 26,795 | A-Award | A | 26,000 | 0.00 | 0.00 |
2024-01-23 | Coulie Bernard | director, officer: President and CEO | 444,532 | A-Award | A | 128,150 | 0.00 | 0.00 |
2024-01-23 | Coulie Bernard | director, officer: President and CEO | 256,300 | A-Award | A | 256,300 | 17.44 | 4,469,872.00 |
2024-01-17 | Cummings Keith Lamont | officer: Chief Financial Officer | 194,605 | S-Sale | D | 9,781 | 17.23 | 168,527.00 |
2024-01-17 | Hull Hans | officer: Chief Business Officer | 185,069 | S-Sale | D | 9,786 | 17.23 | 168,613.00 |
2024-01-17 | Coulie Bernard | director, officer: President and CEO | 316,382 | S-Sale | D | 25,721 | 17.23 | 443,173.00 |
2024-01-17 | Lefebvre Eric | officer: Chief Medical Officer | 156,920 | S-Sale | D | 10,295 | 17.23 | 177,383.00 |
2024-01-17 | Ouimette Mike | officer: General Counsel & Corp. Sec'y | 55,246 | S-Sale | D | 5,197 | 17.23 | 89,544.00 |
2023-08-04 | Hull Hans | officer: Chief Business Officer | 214,905 | M-Exempt | A | 8,791 | 2.08 | 18,285.00 |
2023-08-03 | Hull Hans | officer: Chief Business Officer | 207,914 | M-Exempt | A | 1,800 | 2.08 | 3,744.00 |
2023-08-03 | Hull Hans | officer: Chief Business Officer | 206,114 | S-Sale | A | 1,800 | 20.00 | 36,000.00 |
2023-08-03 | Hull Hans | officer: Chief Business Officer | 206,114 | S-Sale | D | 13,069 | 20.00 | 261,380.00 |
2023-08-04 | Hull Hans | officer: Chief Business Officer | 194,855 | S-Sale | D | 20,050 | 20.01 | 401,201.00 |
2023-08-03 | Hull Hans | officer: Chief Business Officer | 40,158 | M-Exempt | D | 1,800 | 2.08 | 3,744.00 |
2023-08-04 | Hull Hans | officer: Chief Business Officer | 31,367 | M-Exempt | D | 8,791 | 2.08 | 18,285.00 |
2023-07-20 | Ouimette Mike | officer: General Counsel & Corp. Sec'y | 60,443 | S-Sale | D | 4,755 | 17.55 | 83,450.00 |
2023-07-17 | Ouimette Mike | officer: General Counsel & Corp. Sec'y | 65,198 | S-Sale | D | 12,778 | 18.01 | 230,120.00 |
2023-07-17 | Lefebvre Eric | officer: Chief Medical Officer | 167,215 | S-Sale | D | 22,321 | 18.01 | 401,981.00 |
2023-07-17 | Hull Hans | officer: Chief Business Officer | 219,183 | S-Sale | D | 17,937 | 18.01 | 323,029.00 |
2023-07-17 | Cummings Keith Lamont | officer: Chief Financial Officer | 203,999 | S-Sale | D | 19,771 | 18.01 | 356,058.00 |
2023-07-17 | Coulie Bernard | director, officer: President and CEO | 342,103 | S-Sale | D | 70,150 | 18.01 | 1,263,338.00 |
2023-07-14 | Ouimette Mike | officer: General Counsel & Corp. Sec'y | 77,976 | A-Award | A | 27,187 | 0.00 | 0.00 |
2023-07-14 | Lefebvre Eric | officer: Chief Medical Officer | 189,536 | A-Award | A | 43,750 | 0.00 | 0.00 |
2023-07-14 | Hull Hans | officer: Chief Business Officer | 237,120 | A-Award | A | 35,156 | 0.00 | 0.00 |
2023-07-14 | Cummings Keith Lamont | officer: Chief Financial Officer | 223,770 | A-Award | A | 38,750 | 0.00 | 0.00 |
2023-07-14 | Coulie Bernard | director, officer: President and CEO | 412,253 | A-Award | A | 137,500 | 0.00 | 0.00 |
2023-06-13 | Cummings Keith Lamont | officer: Chief Financial Officer | 185,020 | M-Exempt | A | 30,750 | 2.08 | 63,960.00 |
2023-06-13 | Cummings Keith Lamont | officer: Chief Financial Officer | 97,047 | M-Exempt | D | 30,750 | 2.08 | 63,960.00 |
2023-06-09 | Cummings Keith Lamont | officer: Chief Financial Officer | 154,270 | M-Exempt | A | 5,800 | 2.08 | 12,064.00 |
2023-06-09 | Cummings Keith Lamont | officer: Chief Financial Officer | 127,797 | M-Exempt | D | 5,800 | 2.08 | 12,064.00 |
2023-06-07 | Shah Smital | director | 14,000 | A-Award | A | 14,000 | 23.09 | 323,260.00 |
2023-06-07 | PYOTT DAVID E I | director | 14,000 | A-Award | A | 14,000 | 23.09 | 323,260.00 |
2023-06-07 | MCCOURT Thomas A | director | 14,000 | A-Award | A | 14,000 | 23.09 | 323,260.00 |
2023-06-07 | Knobil Katharine | director | 14,000 | A-Award | A | 14,000 | 23.09 | 323,260.00 |
2023-06-07 | Huh Hoyoung | director | 14,000 | A-Award | A | 14,000 | 23.09 | 323,260.00 |
2023-06-07 | Curnutte John T | director | 14,000 | A-Award | A | 14,000 | 23.09 | 323,260.00 |
2023-06-07 | CROWELL GAYLE A | director | 14,000 | A-Award | A | 14,000 | 23.09 | 323,260.00 |
2023-06-07 | Cline Darren S | director | 14,000 | A-Award | A | 14,000 | 23.09 | 323,260.00 |
2023-06-07 | Bruhn Suzanne Louise | director | 14,000 | A-Award | A | 14,000 | 23.09 | 323,260.00 |
2023-03-30 | Ouimette Mike | officer: General Counsel & Corp. Sec'y | 53,666 | S-Sale | D | 4,874 | 26.52 | 129,263.00 |
2023-04-03 | Ouimette Mike | officer: General Counsel & Corp. Sec'y | 50,989 | S-Sale | D | 2,677 | 26.74 | 71,575.00 |
2023-04-03 | Ouimette Mike | officer: General Counsel & Corp. Sec'y | 50,789 | S-Sale | D | 200 | 27.46 | 5,491.00 |
2023-03-30 | Lefebvre Eric | officer: Chief Medical Officer | 145,786 | S-Sale | D | 11,245 | 26.52 | 298,228.00 |
2023-03-30 | Hull Hans | officer: Chief Business Officer | 201,964 | S-Sale | D | 9,036 | 26.52 | 239,643.00 |
2023-03-30 | Cummings Keith Lamont | officer: Chief Financial Officer | 148,470 | S-Sale | D | 9,960 | 26.52 | 264,148.00 |
2023-03-30 | Coulie Bernard | director, officer: President and CEO | 274,753 | S-Sale | D | 35,339 | 26.52 | 937,222.00 |
2023-03-29 | Ouimette Mike | officer: General Counsel & Corp. Sec'y | 58,540 | A-Award | A | 13,593 | 0.00 | 0.00 |
2023-03-29 | Lefebvre Eric | officer: Chief Medical Officer | 157,031 | A-Award | A | 21,874 | 0.00 | 0.00 |
2023-03-29 | Hull Hans | officer: Chief Business Officer | 211,000 | A-Award | A | 17,578 | 0.00 | 0.00 |
2023-03-29 | Cummings Keith Lamont | officer: Chief Financial Officer | 158,430 | A-Award | A | 19,375 | 0.00 | 0.00 |
2023-03-29 | Coulie Bernard | director, officer: President and CEO | 310,092 | A-Award | A | 68,749 | 0.00 | 0.00 |
2023-03-06 | MCCOURT Thomas A | director | 22,000 | A-Award | A | 22,000 | 31.11 | 684,420.00 |
2023-03-06 | MCCOURT Thomas A | director: | 0 | 0 | 0.00 | 0.00 | ||
2023-03-06 | Cline Darren S | director | 22,000 | A-Award | A | 22,000 | 31.11 | 684,420.00 |
2023-03-06 | Cline Darren S | director: | 0 | 0 | 0.00 | 0.00 | ||
2023-02-02 | Coulie Bernard | director, officer: President and CEO | 342,262 | M-Exempt | D | 15,000 | 6.22 | 93,300.00 |
2023-02-03 | Coulie Bernard | director, officer: President and CEO | 327,262 | M-Exempt | D | 15,000 | 6.22 | 93,300.00 |
2023-02-03 | Coulie Bernard | director, officer: President and CEO | 255,112 | M-Exempt | A | 15,000 | 6.22 | 93,300.00 |
2023-02-03 | Coulie Bernard | director, officer: President and CEO | 245,374 | S-Sale | D | 9,738 | 33.36 | 324,888.00 |
2023-02-02 | Coulie Bernard | director, officer: President and CEO | 241,717 | S-Sale | D | 13,395 | 34.13 | 457,124.00 |
2023-02-03 | Coulie Bernard | director, officer: President and CEO | 240,112 | S-Sale | D | 5,262 | 34.08 | 179,312.00 |
2023-02-02 | Coulie Bernard | director, officer: President and CEO | 240,112 | S-Sale | D | 1,605 | 34.96 | 56,105.00 |
2023-01-31 | Coulie Bernard | director, officer: President and CEO | 372,262 | M-Exempt | D | 4,461 | 6.22 | 27,747.00 |
2023-02-01 | Coulie Bernard | director, officer: President and CEO | 357,262 | M-Exempt | D | 15,000 | 6.22 | 93,300.00 |
2023-01-30 | Coulie Bernard | director, officer: President and CEO | 255,112 | M-Exempt | A | 15,000 | 2.08 | 31,200.00 |
2023-02-01 | Coulie Bernard | director, officer: President and CEO | 255,112 | M-Exempt | A | 15,000 | 6.22 | 93,300.00 |
2023-01-31 | Coulie Bernard | director, officer: President and CEO | 250,651 | M-Exempt | A | 10,539 | 2.08 | 21,921.00 |
2023-02-01 | Coulie Bernard | director, officer: President and CEO | 245,657 | S-Sale | D | 9,455 | 34.15 | 322,841.00 |
2023-01-30 | Coulie Bernard | director, officer: President and CEO | 243,717 | S-Sale | D | 11,395 | 33.98 | 387,177.00 |
2023-02-01 | Coulie Bernard | director, officer: President and CEO | 240,217 | S-Sale | D | 5,440 | 34.78 | 189,192.00 |
2023-02-01 | Coulie Bernard | director, officer: President and CEO | 240,112 | S-Sale | D | 105 | 35.55 | 3,733.00 |
2023-01-31 | Coulie Bernard | director, officer: President and CEO | 240,112 | S-Sale | D | 15,000 | 34.92 | 523,755.00 |
2023-01-30 | Coulie Bernard | director, officer: President and CEO | 240,112 | S-Sale | D | 3,605 | 34.66 | 124,938.00 |
2023-01-30 | Coulie Bernard | director, officer: President and CEO | 157,380 | M-Exempt | D | 15,000 | 2.08 | 31,200.00 |
2023-01-31 | Coulie Bernard | director, officer: President and CEO | 146,841 | M-Exempt | D | 10,539 | 2.08 | 21,921.00 |
2023-01-25 | Cummings Keith Lamont | director: Chief Financial Officer | 138,424 | A-Award | A | 54,000 | 0.00 | 0.00 |
2023-01-25 | Cummings Keith Lamont | director: Chief Financial Officer | 76,200 | A-Award | A | 76,200 | 0.00 | 0.00 |
2023-01-25 | Hull Hans | director: Chief Business Officer | 192,191 | A-Award | A | 54,000 | 0.00 | 0.00 |
2023-01-25 | Hull Hans | director: Chief Business Officer | 76,200 | A-Award | A | 76,200 | 0.00 | 0.00 |
2023-01-25 | Ouimette Mike | director: General Counsel & Corp. Sec'y | 55,000 | A-Award | A | 55,000 | 0.00 | 0.00 |
2023-01-25 | Ouimette Mike | director: General Counsel & Corp. Sec'y | 44,947 | A-Award | A | 39,000 | 0.00 | 0.00 |
2023-01-25 | Lefebvre Eric | director: Chief Medical Officer | 133,926 | A-Award | A | 57,000 | 0.00 | 0.00 |
2023-01-25 | Lefebvre Eric | director: Chief Medical Officer | 80,000 | A-Award | A | 80,000 | 0.00 | 0.00 |
2023-01-26 | Coulie Bernard | director: President and CEO | 419,317 | S-Sale | D | 15,000 | 35.10 | 526,425.00 |
2023-01-27 | Coulie Bernard | director: President and CEO | 409,538 | S-Sale | D | 9,779 | 35.09 | 343,158.00 |
2023-01-27 | Coulie Bernard | director: President and CEO | 409,317 | S-Sale | D | 221 | 36.64 | 8,097.00 |
2023-01-27 | Coulie Bernard | director: President and CEO | 255,112 | M-Exempt | A | 15,000 | 2.08 | 31,200.00 |
2023-01-27 | Coulie Bernard | director: President and CEO | 246,414 | S-Sale | D | 8,698 | 35.42 | 308,046.00 |
2023-01-27 | Coulie Bernard | director: President and CEO | 240,112 | S-Sale | D | 6,302 | 36.06 | 227,243.00 |
2023-01-25 | Coulie Bernard | director: President and CEO | 240,112 | A-Award | A | 146,300 | 0.00 | 0.00 |
2023-01-25 | Coulie Bernard | director: President and CEO | 206,300 | A-Award | A | 206,300 | 0.00 | 0.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.